神経血管血栓除去装置/神経血栓除去装置の世界市場：洞察、競合情勢、市場予測：2030年

世界の神経血管血栓除去装置/神経血栓除去装置の市場規模は、2023年に7億2,278万米ドルとなりました。同市場は、2024年から2030年までの予測期間中に6.15%のCAGRで拡大し、2030年には10億3,333万米ドルに達すると予測されています。神経血管血栓除去装置/神経血栓除去装置に対する需要の増加は、虚血性脳卒中や血栓性脳卒中などの治療に神経血管血栓除去装置/神経血栓除去装置を必要とする神経血管障害の世界の有病率の上昇、高齢者人口の増加などが主な要因です。加えて、主要企業が技術的に高度な製品の開発に注力し、神経血管疾患とその予防に関する認知度を高める取り組みを行っていることも、神経血管血栓除去装置/神経血栓除去装置の市場を急拡大させる要因のひとつです。

世界の高齢者人口の増加は、神経血管血栓除去装置/神経血栓除去装置の需要を今後増大させる可能性が高いとみられています。高齢者は脳卒中やその他の神経血管障害の影響を受けやすいからです。World Population Ageing 2020 Highlightsによると、2020年の65歳以上の高齢者数は世界で推定7億2,700万人、2050年には15億人に達すると予測されています。また、世界脳卒中機構の2019年のデータでは、脳卒中全体の60％近くが70歳未満で発生しています。したがって、これらのデバイスは、脳神経血管系の血栓を回収または破壊することを目的としているため、上記のような因子は、潜在的に世界の神経血管血栓除去装置/神経血栓除去装置市場を牽引する可能性があります。

当レポートでは、世界の神経血管血栓除去装置/神経血栓除去装置市場について調査し、市場の概要とともに、製品タイプ別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 神経血管血栓除去装置/神経血栓除去装置レポートイントロダクション

第2章 神経血管血栓除去装置/神経血栓除去装置のエグゼクティブサマリー

第3章 規制と特許の分析

• 米国
• 欧州
• 日本

第4章 神経血管血栓除去装置/神経血栓除去装置市場の主な要因分析

• 神経血管血栓除去装置/神経血栓除去装置市場の促進要因
• 神経血管血栓除去装置/神経血栓除去装置市場の抑制要因と課題
• 神経血管血栓除去装置/神経血栓除去装置市場の機会

第5章 神経血管血栓除去装置/神経血栓除去装置市場におけるポーターのファイブフォース分析

第6章 神経血管血栓除去装置/神経血栓除去装置市場に対するCOVID-19の影響分析

第7章 神経血管血栓除去装置/神経血栓除去装置市場概要ト

• 製品タイプ別
• エンドユーザー別
• 地域別

第8章 神経血管血栓除去装置/神経血栓除去装置の世界企業シェア分析-主要3～5社

第9章 神経血管血栓除去装置/神経血栓除去装置の企業と製品プロファイル

• Stryker
• Penumbra, Inc.
• Vesalio, LLC.
• Acandis GmBH
• Rapid Medical
• Johnson & Johnson
• Teleflex Incorporated
• Medtronic
• NeuroVasc Technologies, Inc.
• Perflow Medical
• Edward LifeSciences Corporation
• Terumo Europe NV
• Koninklijke Philips N.V.
• MicroVention Inc.
• phenox GmbH
• BIOMEDICAL SOLUTIONS INC.
• Ceretrieve Ltd.
• Anaconda Biomed SL
• Genesis Medtech.

第10章 プロジェクトのアプローチ

第11章 KOLの見解

第12章 DelveInsightのサービス内容

第13章 免責事項

第14章 DelveInsightについて

List of Tables

• Table 1: Competitive Analysis
• Table 2: COVID-19 Impact Analysis on Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market
• Table 3: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Global (2021-2030)
• Table 4: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Global by Product Type (2021-2030)
• Table 5: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Global by End User (2021-2030)
• Table 6: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Global by Geography (2021-2030)
• Table 7: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in North America (2021-2030)
• Table 8: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in North America by Product Type (2021-2030)
• Table 9: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in North America by End User (2021-2030)
• Table 10: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in North America by Country (2021-2030)
• Table 11: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in the US (2021-2030)
• Table 12: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Canada (2021-2030)
• Table 13: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Mexico (2021-2030)
• Table 14: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Europe (2021-2030)
• Table 15: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Europe by Product Type (2021-2030)
• Table 16: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Europe by End User (2021-2030)
• Table 17: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Europe by Country (2021-2030)
• Table 18: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in France (2021-2030)
• Table 19: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Germany (2021-2030)
• Table 20: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in the UK (2021-2030)
• Table 21: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Italy (2021-2030)
• Table 22: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Spain (2021-2030)
• Table 23: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Russia (2021-2030)
• Table 24: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Rest of Europe (2021-2030)
• Table 25: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Asia-Pacific (2021-2030)
• Table 26: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Asia-Pacific by Product Type (2021-2030)
• Table 27: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Asia-Pacific by End User (2021-2030)
• Table 28: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Asia-Pacific by Country (2021-2030)
• Table 29: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in China (2021-2030)
• Table 30: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Japan (2021-2030)
• Table 31: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in India (2021-2030)
• Table 32: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Australia (2021-2030)
• Table 33: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in South Korea (2021-2030)
• Table 34: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Rest of Asia-Pacific (2021-2030)
• Table 35: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Rest of World (2021-2030)
• Table 36: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Rest of World by Product Type (2021-2030)
• Table 37: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Rest of World by End User (2021-2030)
• Table 38: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Rest of World by Country (2021-2030)
• Table 39: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in the Middle East (2021-2030)
• Table 40: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Africa (2021-2030)
• Table 41: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: COVID-19 Impact Analysis on Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market
• Figure 3: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Global (2021-2030)
• Figure 4: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Global by Product Type (2021-2030)
• Figure 5: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Global by End User (2021-2030)
• Figure 6: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Global by Geography (2021-2030)
• Figure 7: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in North America (2021-2030)
• Figure 8: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in North America by Product Type (2021-2030)
• Figure 9: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in North America by End User (2021-2030)
• Figure 10: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in North America by Country (2021-2030)
• Figure 11: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in the US (2021-2030)
• Figure 12: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Canada (2021-2030)
• Figure 13: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Mexico (2021-2030)
• Figure 14: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Europe (2021-2030)
• Figure 15: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Europe by Product Type (2021-2030)
• Figure 16: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Europe by End User (2021-2030)
• Figure 17: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Europe by Country (2021-2030)
• Figure 18: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in France (2021-2030)
• Figure 19: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Germany (2021-2030)
• Figure 20: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in the UK (2021-2030)
• Figure 21: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Italy (2021-2030)
• Figure 22: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Spain (2021-2030)
• Figure 23: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Russia (2021-2030)
• Figure 24: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Rest of Europe (2021-2030)
• Figure 25: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Asia-Pacific (2021-2030)
• Figure 26: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Asia-Pacific by Product Type (2021-2030)
• Figure 27: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Asia-Pacific by End User (2021-2030)
• Figure 28: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Asia-Pacific by Country (2021-2030)
• Figure 29: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in China (2021-2030)
• Figure 30: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Japan (2021-2030)
• Figure 31: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in India (2021-2030)
• Figure 32: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Australia (2021-2030)
• Figure 33: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in South Korea (2021-2030)
• Figure 34: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Rest of Asia-Pacific (2021-2030)
• Figure 35: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Rest of World (2021-2030)
• Figure 36: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Rest of World by Product Type (2021-2030)
• Figure 37: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Rest of World by End User (2021-2030)
• Figure 38: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Rest of World by Country (2021-2030)
• Figure 39: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in the Middle East (2021-2030)
• Figure 40: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in Africa (2021-2030)
• Figure 41: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Analysis in South America (2021-2030)
• Figure 42: Market Drivers
• Figure 43: Market Barriers
• Figure 44: Market Opportunities
• Figure 45: PORTER's Five Force Analysis

Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market By Product Type (Clot Retreivers, Aspiration Devices, and Others), By End User (Hospitals, Ambulatory Surgical Centers, and Others), By Geography is anticipated to grow at a static CAGR forecast till 2030 owing to increase in prevalence and incidence of neurovascular disorders such as ischemic stroke, hemmorhagic stroke and introduction of technologically advanced products.

Global Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market was valued at USD 722.78 million in 2023, growing at a CAGR of 6.15% during the forecast period from 2024 to 2030 to reach USD 1033.33 million by 2030. The rise in demand for Neurovascular Thrombectomy Devices/Neurothrombectomy Devices is predominantly imputed to the rising prevalence of neurovascular disorder across the globe which require Neurovascular Thrombectomy Devices/Neurothrombectomy Devices for their treatment such as ischemic stroke and hemmorhagic stroke, growing burden of old age population. In addition, shifting key players focus towards development of technologically advanced product and initiatives to increase awareness regarding neurovascular diseases and their prevention are some of the factors among others that are likely to upsurge the market for Neurovascular Thrombectomy Devices/Neurothrombectomy Devices.

Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Dynamics:

Growing geriatric population worldwide is likely to augment the demand for Neurovascular Thrombectomy Devices/Neurothrombectomy Devices in the forthcoming period. This is because old prople are more susceptible to get affected by strokes and other neurovascular disorders. According to the World Population Ageing 2020 Highlights, there were an estimated 727 million persons aged 65 years or over worldwide in the year 2020 and the number was projected to reach 1.5 billion by the year 2050. Also, as per the World Stroke Organization 2019 data almost 60% of all strokes occur in people under 70 years of age. Thus, the above mentioned fator could potentially drive the global Neurovascular Thrombectomy Devices/Neurothrombectomy Devices market as these devices are intended to retrieve or destroy blood clots in the cerebral neurovasculature.

Moreover, rising incidence and prevalence of neurovascular disorders such as acute ischemic stroke, hemmohragic stroke, and others can also be projected to propel the demand for these devices. According to a study: Facing the stroke burden worldwide by Lanas F. and Seron P. published in LANCET in the year 2023, stroke was the second leading cause of disability-adjusted life-years worldwide in both the 50-74 years and 75 years and older age groups and around 70% of strokes occured in low-income and middle-income countries in which people have proportionally more haemorrhagic strokes in 2019.

In addition, the demand for Neurovascular Thrombectomy Devices/Neurothrombectomy Devices could also surge due to increase in patients who have either failed intravenous recombinant tissue plasminogen activator (IV rtPA) therapy or who are either ineligible for or have contraindications to IV rtPA use. Hence all the factors are expected to bolster the global market for Neurovascular Thrombectomy Devices/Neurothrombectomy Devices.

However, certain factors such as complication with the implementation of Neurovascular Thrombectomy Devices/Neurothrombectomy Devices and few product recalls are expected to slow down the market growth for Neurovascular Thrombectomy Devices/Neurothrombectomy Devices.

Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Segment Analysis:

Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market By Product Type (Clot Retreivers, Aspiration Devices, And Others), By End User (Hospitals, Ambulatory Surgical Centers, And Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the Neurovascular Thrombectomy Devices/Neurothrombectomy Devices product segment, the clot retreivers segment is anticipated to hold the largest share during the forecasted period. This is due to the rising focus of manufacturers towards developing technologically advanced clot retreivers for an improved and efficient removal of clots from the intracranial region. For instance, recently in the year 2020, CERENOVUS, a part of Johnson & Johnson company launched CERENOVUS Stroke Solutions(TM), which includes a suite of three devices designed to aid physicians in clot removal procedures. One of the three devices is EMBOTRAP® III Revascularization Device, the latest generation stent retriever which is designed to engage a wide range of clot types, improve procedural confidence and provide more tailored options to achieve the First Pass Effect (FPE).

Moreover, increase in approval of clot retreivers by the regulatory bodies for the treatment of acute ischemic stroke is also a driving factor for the segmental growth. Recently, in July 2020, Rapid Medical, a company focused on the development of next generation neurovascular devices received CE Mark for TIGERTRIEVER XL, the newest addition to the stent retriever portfolio designed to treat ischemic stroke.

In addition, the aspiration segment is also expected to witness a lucrative growth during the forecasted period owing to its increasing preference by physicians. Few of the prominent aspiration devices in the market are Penumbra System®, AXS Universal Aspiration Set, among others.

North America is expected to dominate the overall Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market:

Among all the countries, North America is anticipated to dominate the overall Neurovascular Thrombectomy Devices/Neurothrombectomy Devices market during the forecast period. This domination is due to the growing government initiatives to raise awareness regarding effective treatment of stroke, proper reimbursement scenario, and presence of an advanced healthcare facilties in the region will boost the Neurovascular Thrombectomy Devices/Neurothrombectomy Devices market.

Further, In the United States, the rising cases of ischemic stroke is anticipated to spur the demand for Neurovascular Thrombectomy Devices/Neurothrombectomy Devices. According to the CDC 2022 report, every year, more than 795,000 people in the United States have a stroke and about 610,000 of these are first or new strokes. In addition, the report also stated that 87% of all strokes are ischemic strokes, in which blood flow to the brain is blocked.

Moreover, presence of key manufacturers such as Johnson & Johnson, Vesalio, Stryker, among others will also boost the market in the region. In addition, product launches by the manufacturers will augment the Neurovascular Thrombectomy Devices/Neurothrombectomy Devices market. For instance, On April 30, 2019, Medtronic announced the commercial launch of Solitaire X revascularization device in the United States. Also, Medtronic introduced the Phenom 21 catheter to facilitate the delivery of all sizes of the Solitaire X device.

Furthermore, Europe will also exhibit a lucrative neurothrombectomy market growth due to the strategic initiative by the market players for market expansion in the region, along with frequent product approvals. For instance, recently in October 2020, CERENOVUS launched the CERENOVUS NIMBUS(TM) in Europe, designed to remove tough clots for successful revascularization in patients with acute ischemic stroke caused by a large vessel occlusion.

In addition, in September 2020, Vesalio LLC entered into exclusive distribution agreements in Europe, Latin America, Asia, and the Middle East that expand market coverage in 53 countries for the company's NeVa neurovascular thrombectomy system for first-pass recanalization in acute ischemic stroke.

Additionally, key companies initiative to access to mechanical thrombectomy for stroke in pilot countries is also expected to have a positive impact on the Neurovascular Thrombectomy Devices/Neurothrombectomy Devices growth in the region. In March 2022, Medtronic and SVIN Mission Thrombectomy 2020+ (MT2020+) enetered into a new and exclusive partnership on the IMMEDIATE program to advance stroke care globally. This unique partnership between MT2020+ and Medtronic will combine specialist expertise from both organizations, thereby transforming and advancing a new standard of care in stroke treatment and accelerate access to mechanical thrombectomy for stroke.

Hence all the above mentioned is expected to grow the regional market for Neurovascular Thrombectomy Devices/Neurothrombectomy Devices.

Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Key Players:

Some of the key market players operating in the Neurovascular Thrombectomy Devices/Neurothrombectomy Devices market include Stryker, Penumbra, Inc., Vesalio, LLC., Acandis GmbH, Rapid Medical, Johnson & Johnson, Teleflex Incorporated, Medtronic, NeuroVasc Technologies, Inc., Perflow Medical, Edward LifeSciences Corporation, Terumo Europe NV, Koninklijke Philips N.V., MicroVention Inc., phenox GmbH, BIOMEDICAL SOLUTIONS INC., Ceretrieve Ltd., Anaconda Biomed SL, Genesis Medtech., and others.

Recent Developmental Activities in the Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market:

In September 2022, NeuroVasc Technologies, Inc. had the first patient treated in a Chinese Pivotal Randomized Controlled Trial to evaluate the safety and efficacy of the ENVI(TM)-SR Mechanical Thrombectomy System (ENVI(TM)-SR), a stent-retriever for the removal of blood clots in patients with acute ischemic stroke due to large vessel occlusion.

In April 2022, Perflow Medical, a private, Israeli-based innovator for neurovascular treatments, had the first successful clinical use of the Stream(TM)17 Dynamic Neuro-Thrombectomy Net, a lower profile device designed for more tortuous anatomy, to effectively treat hemorrhagic and ischemic stroke patients.

In June 2020, Phenox announced the full European launch of the pRESET 5-40 and pRESET LUX 4-20 thrombectomy devices after receiving CE mark approval in the year 2019.

In February 2020, Stryker received the US FDA approval for Trevo NXT ProVue Retriever indicated for use to restore blood flow in the neurovasculature by removing thrombus for the treatment of acute ischemic stroke.

Key Takeaways from the Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Neurovascular Thrombectomy Devices/Neurothrombectomy Devices market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the Global Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market.

Various opportunities available for the other competitor in the Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Neurovascular Thrombectomy Devices/Neurothrombectomy Devices market growth in the coming future?

Target Audience who can be benefited from the Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Report Study

Neurovascular Thrombectomy Devices/Neurothrombectomy Devices providers

Research organizations and consulting companies

Neurovascular Thrombectomy Devices/Neurothrombectomy Devices-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in Neurovascular Thrombectomy Devices/Neurothrombectomy Devices

Various End-users who want to know more about the Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market and the latest technological developments in the Neurovascular Thrombectomy Devices/Neurothrombectomy Devices market.

Frequently Asked Questions for the Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market:

1. What are Neurovascular Thrombectomy Devices/Neurothrombectomy Devices?

Neurovascular thrombectomy devices, also known as cerebral thrombectomy devices, are used to remove or destroy blood clots in the brain region. These devices are also used in patients where pharmacological treatment has not worked effectively.

2. What is the market for Global Neurovascular Thrombectomy Devices/Neurothrombectomy Devices?

Global Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market was valued at USD 722.78 million in 2023, growing at a CAGR of 6.15% during the forecast period from 2024 to 2030 to reach USD 1033.33 million by 2030.

3. What are the drivers for Global Neurovascular Thrombectomy Devices/Neurothrombectomy Devices?

The major factors driving the demand for Neurovascular Thrombectomy Devices/Neurothrombectomy Devices are the growing prevalence of neurological disorders such as acute ischemic stroke, hemmohragic stroke, and others among the population, growing old age population, recent product approvals, and integration of advanced technology in the product portfolio.

4. What are the key players operating in Global Neurovascular Thrombectomy Devices/Neurothrombectomy Devices?

Some of the key market players operating in the Neurovascular Thrombectomy Devices/Neurothrombectomy Devices market include Stryker, Penumbra, Inc., Vesalio, LLC., Acandis GmbH, Rapid Medical, Johnson & Johnson, Teleflex Incorporated, Medtronic, NeuroVasc Technologies, Inc., Perflow Medical, Edward LifeSciences Corporation, Terumo Europe NV, Koninklijke Philips N.V., MicroVention Inc., phenox GmbH, BIOMEDICAL SOLUTIONS INC., Ceretrieve Ltd., Anaconda Biomed SL, Genesis Medtech., and others.

5. Which region has the highest share in Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market?

North America is anticipated to dominate the overall Neurovascular Thrombectomy Devices/Neurothrombectomy Devices market during the forecast period 2024-2030. This domination is due to the growing government initiatives to raise awareness regarding effective treatment of stroke, proper reimbursement scenario, and presence of an advanced healthcare facilties in the region will boost the Neurovascular Thrombectomy Devices/Neurothrombectomy Devices market.

Table of Contents

1.Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Report Introduction

2. Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Executive summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment
• 2.4. Financial Benchmarking

3. Regulatory and Patent Analysis

• 3.1. The United States
• 3.2. Europe
  • 3.2.1. Germany
  • 3.2.2. France
  • 3.2.3. Italy
  • 3.2.4. Spain
  • 3.2.5. The U.K.
• 3.3. Japan

4. Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Key factors analysis

• 4.1. Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Drivers
  • 4.1.1. Rising prevalence of neurological disorder such as stroke
  • 4.1.2. Growing burden of old population
  • 4.1.3. Increasing product approvals
  • 4.1.4. Shifting focus towards development of technologically advanced product
• 4.2. Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Restraints and Challenges
  • 4.2.1. Complication associated with the devices
  • 4.2.2. Fewer Product Recalls
• 4.3. Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Opportunities
  • 4.3.1. Growth opportunities with combinational technique "SOLUMBRA" comprising large-bore aspiration catheters and stent-retriever technique simultaneously
  • 4.3.2. Growth opportunities in the emerging nation

5. Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market

7. Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market layout

• 7.1. By Product Type
  • 7.1.1. Clot Retreivers
  • 7.1.2. Aspiration Devices
  • 7.1.3. Others
• 7.2. By End User
  • 7.2.1. Hospitals
  • 7.2.2. Ambulatory Surgical Centers
  • 7.2.3. Others
• 7.3. By Geography
  • 7.3.1. North America
    • 7.3.1.1. North America Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market, by Product Type
    • 7.3.1.2. North America Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market, by End User
    • 7.3.1.3. North America Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market, by Country
    • 7.3.1.3.1. United States
    • 7.3.1.3.2. Canada
    • 7.3.1.3.3. Mexico
  • 7.3.2. Europe
    • 7.3.2.1. Europe Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market, by Product Type
    • 7.3.2.2. Europe Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market, by End User
    • 7.3.2.3. Europe Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market, by Country
    • 7.3.2.3.1. France
    • 7.3.2.3.2. Germany
    • 7.3.2.3.3. United Kingdom
    • 7.3.2.3.4. Italy
    • 7.3.2.3.5. Spain
    • 7.3.2.3.6. Russia
    • 7.3.2.3.7. Rest of Europe
  • 7.3.3. Asia-Pacific
    • 7.3.3.1. Asia-Pacific Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market, by Product Type
    • 7.3.3.2. Asia-Pacific Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market, by End User
    • 7.3.3.3. Asia-Pacific Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market, by Country
    • 7.3.3.3.1. China
    • 7.3.3.3.2. Japan
    • 7.3.3.3.3. India
    • 7.3.3.3.4. Australia
    • 7.3.3.3.5. South Korea
    • 7.3.3.3.6. Rest of Asia Pacific
  • 7.3.4. Rest of the World (RoW)
    • 7.3.4.1. RoW Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market, by Product Type
    • 7.3.4.2. RoW Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market, by End User
    • 7.3.4.3. RoW Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market, by Region
    • 7.3.4.3.1. Middle East
    • 7.3.4.3.2. Africa
    • 7.3.4.3.3. South America

8. Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Global Company Share Analysis - Key 3-5 Companies

9. Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Company and Product Profiles

• 9.1. Stryker
  • 9.1.1. Company Overview
  • 9.1.2. Company Snapshot
  • 9.1.3. Financial Overview
  • 9.1.4. Product Listing
  • 9.1.5. Entropy
• 9.2. Penumbra, Inc.
  • 9.2.1. Company Overview
  • 9.2.2. Company Snapshot
  • 9.2.3. Financial Overview
  • 9.2.4. Product Listing
  • 9.2.5. Entropy
• 9.3. Vesalio, LLC.
  • 9.3.1. Company Overview
  • 9.3.2. Company Snapshot
  • 9.3.3. Financial Overview
  • 9.3.4. Product Listing
  • 9.3.5. Entropy
• 9.4. Acandis GmBH
  • 9.4.1. Company Overview
  • 9.4.2. Company Snapshot
  • 9.4.3. Financial Overview
  • 9.4.4. Product Listing
  • 9.4.5. Entropy
• 9.5. Rapid Medical
  • 9.5.1. Company Overview
  • 9.5.2. Company Snapshot
  • 9.5.3. Financial Overview
  • 9.5.4. Product Listing
  • 9.5.5. Entropy
• 9.6. Johnson & Johnson
  • 9.6.1. Company Overview
  • 9.6.2. Company Snapshot
  • 9.6.3. Financial Overview
  • 9.6.4. Product Listing
  • 9.6.5. Entropy
• 9.7. Teleflex Incorporated
  • 9.7.1. Company Overview
  • 9.7.2. Company Snapshot
  • 9.7.3. Financial Overview
  • 9.7.4. Product Listing
  • 9.7.5. Entropy
• 9.8. Medtronic
  • 9.8.1. Company Overview
  • 9.8.2. Company Snapshot
  • 9.8.3. Financial Overview
  • 9.8.4. Product Listing
  • 9.8.5. Entropy
• 9.9. NeuroVasc Technologies, Inc.
  • 9.9.1. Company Overview
  • 9.9.2. Company Snapshot
  • 9.9.3. Financial Overview
  • 9.9.4. Product Listing
  • 9.9.5. Entropy
• 9.10. Perflow Medical
  • 9.10.1. Company Overview
  • 9.10.2. Company Snapshot
  • 9.10.3. Financial Overview
  • 9.10.4. Product Listing
  • 9.10.5. Entropy
• 9.11. Edward LifeSciences Corporation
  • 9.11.1. Company Overview
  • 9.11.2. Company Snapshot
  • 9.11.3. Financial Overview
  • 9.11.4. Product Listing
  • 9.11.5. Entropy
• 9.12. Terumo Europe NV
  • 9.12.1. Company Overview
  • 9.12.2. Company Snapshot
  • 9.12.3. Financial Overview
  • 9.12.4. Product Listing
  • 9.12.5. Entropy
• 9.13. Koninklijke Philips N.V.
  • 9.13.1. Company Overview
  • 9.13.2. Company Snapshot
  • 9.13.3. Financial Overview
  • 9.13.4. Product Listing
  • 9.13.5. Entropy
• 9.14. MicroVention Inc.
  • 9.14.1. Company Overview
  • 9.14.2. Company Snapshot
  • 9.14.3. Financial Overview
  • 9.14.4. Product Listing
  • 9.14.5. Entropy
• 9.15. phenox GmbH
  • 9.15.1. Company Overview
  • 9.15.2. Company Snapshot
  • 9.15.3. Financial Overview
  • 9.15.4. Product Listing
  • 9.15.5. Entropy
• 9.16. BIOMEDICAL SOLUTIONS INC.
  • 9.16.1. Company Overview
  • 9.16.2. Company Snapshot
  • 9.16.3. Financial Overview
  • 9.16.4. Product Listing
  • 9.16.5. Entropy
• 9.17. Ceretrieve Ltd.
  • 9.17.1. Company Overview
  • 9.17.2. Company Snapshot
  • 9.17.3. Financial Overview
  • 9.17.4. Product Listing
  • 9.17.5. Entropy
• 9.18. Anaconda Biomed SL
  • 9.18.1. Company Overview
  • 9.18.2. Company Snapshot
  • 9.18.3. Financial Overview
  • 9.18.4. Product Listing
  • 9.18.5. Entropy
• 9.19. Genesis Medtech.
  • 9.19.1. Company Overview
  • 9.19.2. Company Snapshot
  • 9.19.3. Financial Overview
  • 9.19.4. Product Listing
  • 9.19.5. Entropy

10. Project Approach

• 10.1. Secondary Sources
• 10.2. Primary Sources
• 10.3. Data Triangulation
• 10.4. Key Expert Opinions

11. KOL Views

12. DelveInsight Capabilities

13. Disclaimer

14. About DelveInsight